Priority Healthcare Receives Subpoena from the Department of Justice

Priority Healthcare Receives Subpoena from the Department of
Justice 


LAKE MARY, Fla., Nov. 15  /PRNewswire-FirstCall/ -- Priority Healthcare
Corporation (NASDAQ:PHCC) announced that it received a subpoena from the U.S.
Department of Justice(DOJ) requiring the company to provide the DOJ with
certain information regarding the promotion and marketing of Actimmune, a
product manufactured by InterMune, Inc.

The company believes that the materials sought by the DOJ are part of an
ongoing investigation being conducted by the United States Attorney's Office
for the Northern District of California.

The company intends to fully cooperate with the Department of Justice.

About Priority Healthcare Corporation Priority Healthcare Corporation is a
national specialty pharmacy and distributor that provides biopharmaceuticals,
complex therapies, and related disease treatment services.  Priority Healthcare
provides comprehensive programs for patients, payors, physicians, and
pharmaceutical manufacturers for a growing number of disease states, including
cancer, hepatitis C, respiratory and pulmonary conditions, infertility,
rheumatoid arthritis, hemophilia, multiple sclerosis, Parkinson's disease, and
macular degeneration. Additional information regarding Priority Healthcare is
available online at http://www.priorityhealthcare.com/.

Certain statements included in this press release, which are not historical
facts, are forward-looking statements.  Such forward-looking statements are
made pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995.  These forward-looking statements represent our
expectations or beliefs and involve certain risks and uncertainties, including
those described in our public filings with the United States Securities and
Exchange Commission; also including, but not limited to, changes in interest
rates, competitive pressures, changes in customer mix, changes in third party
reimbursement rates, financial stability of major customers, changes in
government regulations or the interpretation of these regulations, changes in
supplier relationships, growth opportunities, cost savings, revenue
enhancements, synergies and other benefits anticipated from acquisition
transactions, difficulties relative to integrating acquired businesses, the
accounting and tax treatment of acquisitions, and asserted and unasserted
claims, which could cause actual results to differ from those in the
forward-looking statements.  The forward-looking statements by their nature
involve substantial risks and uncertainties, certain of which are beyond our
control, and actual results may differ materially depending on a variety of
important factors.  You are cautioned not to place undue reliance on these
forward-looking statements that speak only as of the date herein. 

http://www.newscom.com/cgi-bin/prnh/20030417/PHCLOGO

http://photoarchive.ap.org/

DATASOURCE: Priority Healthcare Corporation



CONTACT:  Stephen Saft, Chief Financial Officer, Priority Healthcare

Corporation, [phone]



Web site:  http://www.priorityhealthcare.com/ 

Copyright